Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 16 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 9701718

    Adenovirus serotype 26 and serotype 35 filovirus vaccines

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  2. US 9675550

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  3. US 9676840

    Anti-CD100 neutralizing antibodies and methods of using the same

    VACCINEX, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  4. US 9675684

    Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

    The United States of America as represented by the Secretary of the Army · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  5. US 9669091

    Vaccines having an antigen and interleukin-23 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  6. US 9624475

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  7. US 9616115

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  8. US 9605055

    Anti-CD100 antibodies and methods of using the same

    VACCINEX, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  9. US 9603922

    Modulation of NKT cell activity with antigen-loaded CD1d molecules

    VACCINEX, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  10. US 9598495

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  11. US 9566329

    Live, attenuated rubella vector to express vaccine antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  12. US 9566320

    Mucin-associated surface protein as vaccine against Chagas disease

    The Board of Regents of the University of Texas System · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  13. US 9555099

    Vaccines for HSV-2

    IMMUNE DESIGN CORP. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  14. US 9555100

    Herpes virus vaccine and methods of use

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  15. US 9555090

    Equine encephalitis virus vaccines and methods of using thereof

    The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  16. US 9528094

    Attenuated African swine fever virus vaccine based in the deletion of MGF genes

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  17. US 9517262

    Vaccine injection, preparation method and use thereof

    CHINA 302 MILITARY HOSPITAL OF PLA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  18. US 9518096

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  19. US 9512224

    Use of semaphorin-4D binding molecules for treatment of atherosclerosis

    VACCINEX, INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  20. US 9498526

    Human rotavirus vaccine strains and diagnostics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  21. US 9492523

    Broadly protective Shigella vaccine based on type III secretion apparatus proteins

    The Board of Regents for Oklahoma State University · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  22. US 9486518

    Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  23. US 9474795

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  24. US 9474793

    Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.